小髙 雅人(Masahito Kotaka) 役職:research_staff_7_position 2019年 英文論文SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer 国内講演大腸癌チーム医療セミナー in IWATE市民公開講座 知ろう大腸がん!知れば安心!大腸がん治療最前線Chugai Colorectal Cancer Symposiu in KOBECancer VTEセミナー 2018年 英文論文Tumor sidedness and enriched gene groups for efficacy of first-line cetuximab treatment in metastatic colorectal cancerPhase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxaneA prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trialSafety data from the phase III Japanese ACHIEVE trial: part of an international,prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancerA phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as、 second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trialProphylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402)A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study 国内講演消化器がんセミナーin熊谷2018大腸癌治療セミナー in Kobe大腸がんセミナーin塩釜第56回日本癌治療学会学術集会桑名地区消化器癌治療講演会垂水区消化器癌化学療法セミナー消化器がんチーム医療セミナーColorectal Cancer Symposium in Shidahaibara大腸がんチーム医療講演会in Kawasaki ~がん化学療法におけるチーム医療の実際~Meet The Expert西区がん化学療法講演会大腸がんチーム医療セミナー垂水消化器癌連携セミナーColorectal Cancer Winter Forum 2017年 英文論文CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer 国内講演消化器がんチーム医療セミナー ~がん化学療法におけるチーム医療の実際~大腸癌チーム医療セミナーin 都城